BioSpace News Archive

Business

Arcus Biosciences Announces Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates

Advanced three molecules into randomized Phase 2 trials to evaluate Arcus’s potential best-in-class therapies and highly differentiated therapeutic combinations

March 5, 2020
·
10 min read
Business

CooperCompanies Announces First Quarter 2020 Results

CooperCompanies announced financial results for the fiscal first quarter ended January 31, 2020.

March 5, 2020
·
18 min read
Business

CytoSorbents Announces 2019 Financial and Operational Results

2019 Total Revenue was $24.9 million, with 2019 Product Sales of $22.8M, and blended product gross margins of 80% for Q4 2019

March 5, 2020
·
18 min read
Business

Enzo Biochem Reports Fiscal Second Quarter Results 2020

Approval of Proprietary GenFlex™ Platform Is Significant Milestone and Validates Ability to Leverage Leading Intellectual Property

March 5, 2020
·
13 min read
Deals

TransEnterix Announces Launch of Underwritten Public Offering - March 5, 2020

TransEnterix, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, announced that it has commenced an underwritten offering of units.

March 5, 2020
·
3 min read
Biotech Beach

Vital Data Technology’s Affinite™ Quality™ Solution Achieves Full HEDIS® Certification for 2020 Season

Vital Data Technology, LLC announced Affinitē™ Quality™ has been awarded full Healthcare Effectiveness Data and Information Set Certified MeasuresSM status by the National Committee for Quality Assurance.

March 5, 2020
·
3 min read
Business

ElevateBio Appoints Kareem Reda as Chief Business Officer

ElevateBio, a Cambridge-based cell and gene therapy holding company, announced that Kareem Reda has been appointed to the newly created position of Chief Business Officer.

March 5, 2020
·
3 min read
Pharm Country

Cigna Covers Cost Of Coronavirus Tests For Customers

Cigna customers will have access to coronavirus testing, as prescribed by health practitioners, and the company will waive all co-pays or cost-shares to help fight the rapid spread of the virus in the U.S. and for its globally mobile customers..

March 5, 2020
·
3 min read
Deals

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - March 5, 2020

Puma Biotechnology, Inc. announced that on March 4, 2020 the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering an aggregate of 31,125 shares of Puma common stock to five new non-executive employees.

March 5, 2020
·
2 min read
Policy

Updated National Safety Council Statement on Coronavirus, or COVID-19

Since our last statement on Jan. 31, the National Safety Council has continued to follow the data about the coronavirus, or COVID-19.

March 5, 2020
·
2 min read